AU Patent

AU3760300A — Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors

Assigned to Brigham and Womens Hospital Inc · Expires 2000-10-09 · 26y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: AU3760300A
Jurisdiction: AU
Classification: —
Expires: 2000-10-09
Drug substance claim: No
Drug product claim: No
Assignee: Brigham and Womens Hospital Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.